HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells
Authors:
- Lin YeLYLin Ye
- Jonathan M. Lewis-RussellJLJonathan M. Lewis-Russell
- Andrew J. SandersASAndrew J. Sanders
- Howard KynastonHKHoward Kynaston
- Wen G. JiangWen G. Jiang
- 1 March 2008
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 26 (2) , 190-197
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Bone Morphogenetic Protein signaling in joint homeostasis and diseaseCytokine & Growth Factor Reviews, 2005
- Hepatocyte growth factor, its receptor, and their potential value in cancer therapiesCritical Reviews in Oncology/Hematology, 2005
- Signal transduction of bone morphogenetic protein receptorsCellular Signalling, 2004
- The Bone Morphogenetic Protein System In Mammalian ReproductionEndocrine Reviews, 2004
- The HGF/SF antagonist NK4 reverses fibroblast‐ and HGF‐induced prostate tumor growth and angiogenesis in vivoInternational Journal of Cancer, 2003
- Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonistCarcinogenesis, 2003
- Metastatic patterns of prostate cancer: An autopsy study of 1,589 patientsHuman Pathology, 2000
- Reversion of Human Glioblastoma Malignancy by U1 Small Nuclear RNA/Ribozyme Targeting of Scatter Factor/Hepatocyte Growth Factor and c-met ExpressionJNCI: Journal of the National Cancer Institute, 1999
- The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adultEuropean Journal of Oral Sciences, 1998
- The bone morphogenetic protein family and osteogenesisMolecular Reproduction and Development, 1992